File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Evaluation of the new AJCC/UICC staging system for hepatocellular carcinoma after hepatic resection in Chinese patients

TitleEvaluation of the new AJCC/UICC staging system for hepatocellular carcinoma after hepatic resection in Chinese patients
Authors
Issue Date2003
PublisherWB Saunders Co. The Journal's web site is located at http://www.surgonc.theclinics.com/
Citation
Surgical Oncology Clinics Of North America, 2003, v. 12 n. 1, p. 35-50 How to Cite?
AbstractHepatic resection is considered the treatment of choice for HCC; however, the prognosis of patients after resection of HCC varies widely, depending on the clinicopathologic features. The American Joint Committee on Cancer (AJCC)/International Union Against Cancer (UICC) tumor-node-metastasis (TNM) staging system is widely used evaluating patients with HCC. The current TNM staging for HCC uses pathologic characteristics of tumors, including size, number and location of tumor nodules, presence of vascular invasion, perforation of visceral peritoneum, and invasion of adjacent organs as criteria for T staging. Recently, a simplified AJCC/UICC staging for HCC has been proposed. In addition, the Liver Cancer Study Group of Japan proposed a new simplified staging system based on number of tumor nodules, size of tumors, and invasion into the portal vein, hepatic vein, or bile duct. This article evaluates the prognostic value of the new AJCC/UICC TNM staging and the new Japanese staging in a large cohort of Chinese patients who underwent hepatectomy for HCC in a single institution.
Persistent Identifierhttp://hdl.handle.net/10722/172820
ISSN
2015 Impact Factor: 1.958
2015 SCImago Journal Rankings: 0.859
References

 

DC FieldValueLanguage
dc.contributor.authorPoon, RTPen_US
dc.contributor.authorFan, STen_US
dc.date.accessioned2012-10-30T06:25:06Z-
dc.date.available2012-10-30T06:25:06Z-
dc.date.issued2003en_US
dc.identifier.citationSurgical Oncology Clinics Of North America, 2003, v. 12 n. 1, p. 35-50en_US
dc.identifier.issn1055-3207en_US
dc.identifier.urihttp://hdl.handle.net/10722/172820-
dc.description.abstractHepatic resection is considered the treatment of choice for HCC; however, the prognosis of patients after resection of HCC varies widely, depending on the clinicopathologic features. The American Joint Committee on Cancer (AJCC)/International Union Against Cancer (UICC) tumor-node-metastasis (TNM) staging system is widely used evaluating patients with HCC. The current TNM staging for HCC uses pathologic characteristics of tumors, including size, number and location of tumor nodules, presence of vascular invasion, perforation of visceral peritoneum, and invasion of adjacent organs as criteria for T staging. Recently, a simplified AJCC/UICC staging for HCC has been proposed. In addition, the Liver Cancer Study Group of Japan proposed a new simplified staging system based on number of tumor nodules, size of tumors, and invasion into the portal vein, hepatic vein, or bile duct. This article evaluates the prognostic value of the new AJCC/UICC TNM staging and the new Japanese staging in a large cohort of Chinese patients who underwent hepatectomy for HCC in a single institution.en_US
dc.languageengen_US
dc.publisherWB Saunders Co. The Journal's web site is located at http://www.surgonc.theclinics.com/en_US
dc.relation.ispartofSurgical Oncology Clinics of North Americaen_US
dc.subject.meshAdulten_US
dc.subject.meshCarcinoma, Hepatocellular - Pathology - Surgeryen_US
dc.subject.meshChinaen_US
dc.subject.meshCohort Studiesen_US
dc.subject.meshFemaleen_US
dc.subject.meshHepatectomyen_US
dc.subject.meshHumansen_US
dc.subject.meshLiver Cirrhosis - Complications - Pathologyen_US
dc.subject.meshLiver Neoplasms - Pathology - Surgeryen_US
dc.subject.meshMaleen_US
dc.subject.meshMiddle Ageden_US
dc.subject.meshNeoplasm Stagingen_US
dc.subject.meshPrognosisen_US
dc.subject.meshSurvival Analysisen_US
dc.titleEvaluation of the new AJCC/UICC staging system for hepatocellular carcinoma after hepatic resection in Chinese patientsen_US
dc.typeArticleen_US
dc.identifier.emailPoon, RTP: poontp@hkucc.hku.hken_US
dc.identifier.emailFan, ST: stfan@hku.hken_US
dc.identifier.authorityPoon, RTP=rp00446en_US
dc.identifier.authorityFan, ST=rp00355en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1016/S1055-3207(02)00086-8en_US
dc.identifier.pmid12735128-
dc.identifier.scopuseid_2-s2.0-0037271963en_US
dc.identifier.hkuros77822-
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-0037271963&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume12en_US
dc.identifier.issue1en_US
dc.identifier.spage35en_US
dc.identifier.epage50en_US
dc.publisher.placeUnited Statesen_US
dc.identifier.scopusauthoridPoon, RTP=7103097223en_US
dc.identifier.scopusauthoridFan, ST=7402678224en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats